Ricin: Information and Guidance for Clinicians
- Background
Background information on ricin as a bioterrorism agent… - Epidemiology
Agent, transmission, risk groups, pathogenesis… - Suspected Intentional Release
Overview of a suspected intentional release, mental health.… - Clinical Description
Clinical suspicion, symptoms… - Diagnosis & Laboratory Guidance
Clinical & laboratory diagnosis, differential diagnosis, laboratory guidance… - Treatment
General information, treatment recommendations…
- Prevention
No prophylaxis exists… - Surveillance & Reporting
Case definition, surveillance, reporting … - Control Measures
Incident site management, healthcare facility preparedness, decontamination/infection control… - Patient Education
Links to education materials… - Clinician Training
Clinical practice, references … - Other Resources
Sign up for the clinician registry, overviews, translation in Spanish…
Contact CDC
- 800-CDC-INFO
888-232-6348 (TTY)
COCA E-mail: coca@cdc.gov
Public E-mail:
cdcinfo@cdc.gov
Clinician Feedback Form
- Page last reviewed: November 18, 2015
- Page last updated: April 17, 2013
- Content source: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
- Maintained By: